KLK3 and posterior cortical atrophy: Because of growing concerns about overdiagnosis and overtreatment of indolent and early-stage PCa, the United States Preventive Services Task Force (USPSTF) recommended against the routine use of the prostate-specific antigen (PSA) testing for PCa screening [3–7].